Metraipolis › archive › dc_f2ca7542f731

Immune Checkpoint Inhibitor-induced Hepatitis, an Emerging Issue in Precision Cancer Therapy Era: A Narrative Literature Review — Europe PMC PMID:41605828

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41605828
DOI
10.5041/rmmj.10571
License (as archived)
solo-consultazione
Archived
2026-11-06T11:36:21.399Z
SHA-256 of the archived text
20f1427c288e9cb037eced4cc0f49e773699d5141c0cd6fd05e99c95f4fc1131
Stable URL of this page
https://metraipolis.com/documento/dc_f2ca7542f731

How to cite

Immune Checkpoint Inhibitor-induced Hepatitis, an Emerging Issue in Precision Cancer Therapy Era: A Narrative Literature Review — Europe PMC PMID:41605828 — Europe PMC (en), https://europepmc.org/article/MED/41605828 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f2ca7542f731 (Metraipolis archive dc_f2ca7542f731, sha256 20f1427c288e9cb037eced4cc0f49e773699d5141c0cd6fd05e99c95f4fc1131)
BibTeX
@misc{dcf2ca7542f731,
  title = {Immune Checkpoint Inhibitor-induced Hepatitis, an Emerging Issue in Precision Cancer Therapy Era: A Narrative Literature Review — Europe PMC PMID:41605828},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41605828},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f2ca7542f731; sha256 20f1427c288e9cb037eced4cc0f49e773699d5141c0cd6fd05e99c95f4fc1131},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41605828. Agents can read the archived copy with the MCP tool read_document.